AbbVie Inc. CDR Logo

AbbVie Inc. CDR (ABBV)

TSX

Currency in CAD
37.04
+0.07 (+0.19%)

Closed

Aug 25, 2026

Day's Range

36.79
37.04

52 wk Range

26.89
37.16

Overview - ABBV - AbbVie Inc. CDR

Key Statistics

Valuation

Enterprise Value

708.55B

P/E (Trailing)

‪71.23‬

PEG Ratio

‪0.25‬

Price / Sales (TTM)

‪10.56‬

Price / Book

‪-105.15‬

EV / EBITDA

‪31.20‬

Profitability

Gross Margin

‪74.74%‬

Profit Margin

‪70.23%‬

Operating Margin

‪15.51%‬

Return on Assets

‪3.12%‬

Return on Equity

‪-129.67%‬

Ownership

Shares Outstanding

1.76B

Price stats

50-Day Avg

‪34.54‬

200-Day Avg

‪31.81‬

Dividends

Frequency

Quarterly

Shariah Compliance

Shariah Compliant

Report Date: Feb 18, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - ABBV - AbbVie Inc. CDR

Peers - ABBV - AbbVie Inc. CDR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on TSX.

Profile Summary - ABBV - AbbVie Inc. CDR

About

AbbVie Inc. CDR is a Canadian Depositary Receipt that provides Canadian investors with exposure to AbbVie Inc., a research-based biopharmaceutical company, trading in Canadian dollars with a currency hedge to minimize foreign exchange risk. AbbVie Inc. engages in the discovery, development, manufacturing, and sale of…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees57K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.